Published in Pediatr Nephrol on July 20, 2011
First-attack pediatric hypertensive crisis presenting to the pediatric emergency department. BMC Pediatr (2012) 0.91
Therapy of acute hypertension in hospitalized children and adolescents. Curr Hypertens Rep (2014) 0.85
Evaluation and management of pediatric hypertensive crises: hypertensive urgency and hypertensive emergencies. Open Access Emerg Med (2012) 0.81
Reninoma: an uncommon cause of Renin-mediated hypertension. Front Pediatr (2014) 0.77
Anesthetic management of hypertensive crisis in a three-year-old patient with undiagnosed severe renal artery stenosis: a case report. Korean J Anesthesiol (2014) 0.75
Hypertension in children in emergency department. J Renal Inj Prev (2016) 0.75
Aggressive blood pressure control for chronic kidney disease unmasks moyamoya! Clin Kidney J (2013) 0.75
Hypertensive crisis in children: an experience in a single tertiary care center in Korea. Clin Hypertens (2016) 0.75
Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control (2016) 0.75
Treatment Strategies for Paradoxical Hypertension Following Surgical Correction of Coarctation of the Aorta in Children. World J Pediatr Congenit Heart Surg (2017) 0.75
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol (2008) 7.50
Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics (2004) 4.18
Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J (2004) 3.14
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Aldosterone secretion and primary and malignant hypertension. J Clin Invest (1960) 2.48
Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res (2010) 2.28
Cocaine-related medical problems: consecutive series of 233 patients. Am J Med (1990) 2.19
Renovascular hypertension in children. Lancet (2008) 2.17
Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. Acad Emerg Med (1995) 2.07
Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol (2008) 1.90
Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol (2001) 1.83
A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol (2006) 1.62
Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci (Lond) (1981) 1.59
Paragangliomas: etiology, presentation, and management. Cardiol Rev (2009) 1.52
Neonatal hypertension: diagnosis and management. Pediatr Nephrol (2000) 1.51
Spectrum of hypertension in post transplant. J Assoc Physicians India (2010) 1.47
Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis (2002) 1.46
Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol (2007) 1.40
Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol (1996) 1.36
Monitoring arterial blood pressure: what you may not know. Crit Care Nurse (2002) 1.33
The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr (2001) 1.28
Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int (1999) 1.28
Hypertensive crisis. Cardiol Rev (2010) 1.27
Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis (2005) 1.25
Pericardial disorders occurring during open-label study of 1,869 severely hypertensive patients treated with minoxidil. J Cardiovasc Pharmacol (1980) 1.22
Treatment of neonatal hypertension with enalaprilat. J Pediatr (1990) 1.17
Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr (2001) 1.17
Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling. Nat Clin Pract Nephrol (2007) 1.16
Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg (1998) 1.12
Blindness and paraplegia in severe childhood hypertension. Lancet (1979) 1.05
Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol (1977) 1.04
Preoperative pharmacological management of phaeochromocytoma. Neth J Med (2006) 1.00
Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res (2008) 0.99
Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients. Semin Dial (2008) 0.96
Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol (2005) 0.95
Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med (2010) 0.93
Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J Forensic Sci (2009) 0.92
Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics (2001) 0.91
Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension (1982) 0.90
Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr (1975) 0.90
Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children: comparison with central aortic pressure measurements. Am J Cardiol (1983) 0.90
Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med (2011) 0.89
Malignant hypertension: mechanisms and management. Pharmacol Ther (1980) 0.88
Renovascular hypertension in children. Pediatrics (1970) 0.88
Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants. J Perinat Med (2008) 0.88
Management of hypertensive emergencies. Arch Dis Child (1992) 0.88
Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int (1994) 0.86
The sympathetic nervous system in clinical and experimental hypertension. Kidney Int (1986) 0.86
Malignant hypertension - the role of the paracrine renin-angiotensin system. J Pathol (2000) 0.85
Accuracy of oscillometric devices in children and adults. Blood Press (2010) 0.85
Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens (1998) 0.85
Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant (2003) 0.84
Hypertension in children and adolescents: an approach to management of complex hyper-tension in pediatric patients. Curr Hypertens Rep (2009) 0.83
Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens (Greenwich) (2010) 0.82
Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3. Pediatrics (1983) 0.82
The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther (2003) 0.81
Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol. Arch Intern Med (1987) 0.81
Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients. BMC Anesthesiol (2008) 0.80
Isradipine therapy in hypertensive pediatric patients. Ann Pharmacother (1997) 0.80
Management of severe hypertension in a child with tuberous sclerosis-related major vascular abnormalities. J Hypertens (2006) 0.79
Ventricular arrhythmia following short-acting nifedipine administration. Pediatr Nephrol (2005) 0.79
Investigating mineralocorticoid hypertension. J Hypertens Suppl (2003) 0.79
ACE inhibition scintigraphy in the management of hypertension in children. Pediatr Nephrol (1999) 0.78
Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics (1986) 0.78
At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension. Pediatr Nephrol (2008) 0.78
Intravenously administered labetalol for treatment of hypertension in children. J Pediatr (1992) 0.77
Primary hyperparathyroidism in a young adult presenting with severe hypertension. J Pediatr Endocrinol Metab (2010) 0.77
Pediatric arterial interventions. Tech Vasc Interv Radiol (2010) 0.77
Acute hypertension due to phenylephrine eyedrops in a newborn. Can J Ophthalmol (2007) 0.76
Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol (1998) 0.76
Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol (1991) 0.76
The renin-angiotensin system and the pathogenesis of vascular disease in malignant hypertension. Clin Sci Mol Med Suppl (1976) 0.76
Clonidine lowers blood pressure independently of renin suppression in patients with unilateral renal artery stenosis. Chest (1983) 0.75
Pathophysiology, clinical aspects, and treatment of hypertensive crises. Prog Cardiovasc Dis (1989) 0.75
Theophylline toxicity in children. J Pediatr (1986) 0.75
Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome. Pediatr Emerg Care (2007) 0.75
Single-dose captopril scintigraphy in the neonate with renovascular hypertension: prediction of renal failure, a side effect of captopril therapy. Biol Neonate (1988) 0.75
Hypertensive rebound after angiotensin converting enzyme inhibitor withdrawal in diabetic patients with chronic renal failure. Nephrol Dial Transplant (2001) 0.75
Renal manifestations in toddlers with Takayasu's arteritis and malignant hypertension. Pediatr Nephrol (2008) 1.53
A functional immature model of chronic partial ureteral obstruction. Kidney Int (2004) 1.48
Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol (2003) 1.32
Proteinuria in children infected with the human immunodeficiency virus. J Pediatr (2008) 1.24
Rituximab therapy for juvenile-onset systemic lupus erythematosus. Pediatr Nephrol (2007) 1.14
Twenty-five years of infant dialysis: a single center experience. J Pediatr (2009) 1.06
Obesity and preterm birth: additive risks in the progression of kidney disease in children. Pediatr Nephrol (2009) 1.03
Comparative renal histomorphometry: a case study of oligonephropathy of prematurity. Pediatr Nephrol (2005) 0.98
Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol (2011) 0.96
Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr Nephrol (2004) 0.92
Profiling proteinuria in pediatric patients. Pediatr Nephrol (2006) 0.89
Renal manifestations of sexually transmitted diseases: sexually transmitted diseases and the kidney. Adolesc Med Clin (2005) 0.83
Role of routine urinalysis in asymptomatic pediatric patients. Clin Pediatr (Phila) (2005) 0.82
Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediatr Nephrol (2003) 0.82
Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol (2006) 0.81
Angiotensin blockade as sole treatment for proteinuric kidney disease in children. Nephrol Dial Transplant (2007) 0.76